|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakao A, Fujii T, Sugimoto H, Kanazumi N,
Nomoto S, Kodera Y, Inoue S and Takeda S: Oncological problems in
pancreatic cancer surgery. World J Gastroenterol. 12:4466–4472.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsuno S, Egawa S, Fukuyama S, Motoi F,
Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, et al:
Pancreatic cancer registry in Japan: 20 years of experience.
Pancreas. 28:219–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carpelan-Holmström M, Nordling S, Pukkala
E, Sankila R, Lüttges J, Klöppel G and Haglund C: Does anyone
survive pancreatic ductal adenocarcinoma? A nationwide study
re-evaluating the data of the finnish cancer registry. Gut.
54:385–387. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wagner M, Redaelli C, Lietz M, Seiler CA,
Friess H and Büchler MW: Curative resection is the single most
important factor determining outcome in patients with pancreatic
adenocarcinoma. Br J Surg. 91:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neoptolemos JP, Stocken DD, Friess H,
Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C,
Lacaine F, et al: A randomized trial of chemoradiotherapy and
chemotherapy after resection of pancreatic cancer. N Engl J Med.
350:1200–1210. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neoptolemos JP, Stocken DD, Bassi C,
Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger
S, Mariette C, et al: Adjuvant chemotherapy with fluorouracil plus
folinic acid vs. gemcitabine following pancreatic cancer resection:
A randomized controlled trial. JAMA. 304:1073–1081. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oettle H, Post S, Neuhaus P, Gellert K,
Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C,
et al: Adjuvant chemotherapy with gemcitabine vs observation in
patients undergoing curative-intent resection of pancreatic cancer:
A randomized controlled trial. JAMA. 297:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwon WS, Rha SY, Choi YH, Lee JO, Park KH,
Jung JJ, Kim TS, Jeung HC and Chung HC: Ribonucleotide reductase M1
(RRM1) 2464G>A polymorphism shows an association with
gemcitabine chemosensitivity in cancer cell lines. Pharmacogenet
Genomics. 16:429–438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jordheim LP, Sève P, Trédan O and Dumontet
C: The ribonucleotide reductase large subunit (RRM1) as a
predictive factor in patients with cancer. Lancet Oncol.
12:693–702. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakahira S, Nakamori S, Tsujie M,
Takahashi Y, Okami J, Yoshioka S, Yamasaki M, Marubashi S, Takemasa
I, Miyamoto A, et al: Involvement of ribonucleotide reductase M1
subunit overexpression in gemcitabine resistance of human
pancreatic cancer. Int J Cancer. 120:1355–1363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosell R, Felip E, Taron M, Majo J, Mendez
P, Sanchez-Ronco M, Queralt C, Sanchez JJ and Maestre J: Gene
expression as a predictive marker of outcome in stage IIB-IIIA-IIIB
non-small cell lung cancer after induction gemcitabine-based
chemotherapy followed by resectional surgery. Clin Cancer Res.
10:4215s–4219s. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim R, Tan A, Lai KK, Jiang J, Wang Y,
Rybicki LA and Liu X: Prognostic roles of human equilibrative
transporter 1 (hENT-1) and ribonucleoside reductase subunit M1
(RRM1) in resected pancreatic cancer. Cancer. 117:3126–3134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakagawa N, Murakami Y, Uemura K, Sudo T,
Hashimoto Y, Kondo N and Sueda T: Combined analysis of intratumoral
human equilibrative nucleoside transporter 1 (hENT1) and
ribonucleotide reductase regulatory subunit M1 (RRM1) expression is
a powerful predictor of survival in patients with pancreatic
carcinoma treated with adjuvant gemcitabine-based chemotherapy
after operative resection. Surgery. 153:565–575. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sobin LH and Wittekind CH: TNM
Classification of Malignant Tumors. 6th. John Wiley & Sons; New
York, NY: 2002
|
|
16
|
Büchler MW, Friess H, Wagner M, Kulli C,
Wagener V and Z'Graggen K: Pancreatic fistula after pancreatic head
resection. Br J Surg. 87:883–889. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wagner M, Z'graggen K, Vagianos CE,
Redaelli CA, Holzinger F, Sadowski C, Kulli C, Zimmermann H, Baer
HU and Büchler MW: Pylorus-preserving total pancreatectomy. Early
and late results. Dig Surg. 18:188–195. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andrén-Sandberg A, Wagner M, Tihanyi T,
Löfgren P and Friess H: Technical aspects of left-sided pancreatic
surgery for cancer. Dig Surg. 16:305–312. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seiler CA, Wagner M, Sadowski C, Kulli C
and Büchler MW: Randomized prospective trial of pylorus-preserving
vs. Classic duodenopancreatectomy (Whipple procedure): Initial
clinical results. J Gastrointest Surg. 4:443–452. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valsecchi ME, Holdbrook T, Leiby BE,
Pequignot E, Littman SJ, Yeo CJ, Brody JR and Witkiewicz AK: Is
there a role for the quantification of RRM1 and ERCC1 expression in
pancreatic ductal adenocarcinoma? BMC Cancer. 12:1042012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maréchal R, Bachet JB, Mackey JR, Dalban
C, Demetter P, Graham K, Couvelard A, Svrcek M, Bardier-Dupas A,
Hammel P, et al: Levels of gemcitabine transport and metabolism
proteins predict survival times of patients treated with
gemcitabine for pancreatic adenocarcinoma. Gastroenterology.
143:664–674, e1-e6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie H, Jiang W, Jiang J, Wang Y, Kim R and
Liu X and Liu X: Predictive and prognostic roles of ribonucleotide
reductase M1 in resectable pancreatic adenocarcinoma. Cancer.
119:173–181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akita H, Zheng Z, Takeda Y, Kim C, Kittaka
N, Kobayashi S, Marubashi S, Takemasa I, Nagano H, Dono K, et al:
Significance of RRM1 and ERCC1 expression in resectable pancreatic
adenocarcinoma. Oncogene. 28:2903–2909. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elledge SJ, Zhou Z and Allen JB:
Ribonucleotide reductase: Regulation, regulation, regulation.
Trends Biochem Sci. 17:119–123. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reichard P: From RNA to DNA, why so many
Ribonucleotide reductases? Science. 260:1773–1777. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giovannetti E, Mey V, Nannizzi S,
Pasqualetti G, Del Tacca M and Danesi R: Pharmacogenetics of
anticancer drug sensitivity in pancreatic cancer. Mol Cancer Ther.
5:1387–1395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Povoski SP, Karpeh MS Jr, Conlon KC,
Blumgart LH and Brennan MF: Association of preoperative biliary
drainage with postoperative outcome following
pancreaticoduodenectomy. Ann Surg. 230:131–142. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA,
Campbell KA, Sauter PK, Coleman J, Abrams RA and Hruban RH:
Pancreaticoduodenectomy with or without distal gastrectomy and
extended retroperitoneal lymphadenectomy for periampullary
adenocarcinoma, part 2: Randomized controlled trial evaluating
survival, morbidity, and mortality. Ann Surg. 236:355–368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawai M, Tani M, Terasawa H, Ina S, Hirono
S, Nishioka R, Miyazawa M, Uchiyama K and Yamaue H: Early removal
of prophylactic drains reduces the risk of intra-abdominal
infections in patients with pancreatic head resection: Prospective
study for 104 consecutive patients. Ann Surg. 244:1–7. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munoz-Bongrand N, Sauvanet A, Denys A,
Sibert A, Vilgrain V and Belghiti J: Conservative management of
pancreatic fistula after pancreaticoduodenectomy with
pancreaticogastrostomy. J Am Coll Surg. 199:198–203. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tran KT, Smeenk HG, van Eijck CH, Kazemier
G, Hop WC, Greve JW, Terpstra OT, Zijlstra JA, Klinkert P and
Jeekel H: Pylorus preserving pancreaticoduodenectomy versus
standard Whipple procedure: A prospective, randomized, multicenter
analysis of 170 patients with pancreatic and periampullary tumors.
Ann Surg. 240:738–745. 2004. View Article : Google Scholar : PubMed/NCBI
|
